Jim Cramer on Super Micro Computer and Other Stocks

3. GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Number of Hedge Fund Holders: 49

When asked if it is a good time to get back in the stock, Cramer said:

“It just had a very big run… Sells 21 times earnings. I wouldn’t be surprised. I feel like many analysts hate it. I’d wait for another downgrade and buy more. I would not buy more right here. One of these analysts will flinch and downgrade it. They hate the stock.”

GE HealthCare Technologies Inc. (NASDAQ:GEHC) specializes in the development, production, and marketing of a diverse range of products and services aimed at improving patient diagnosis, treatment, and monitoring. The company’s offerings include advanced imaging technologies, ultrasound devices, patient monitoring systems, and diagnostic agents, all designed to improve clinical outcomes.

During the second quarter, GE HealthCare (NASDAQ:GEHC) announced a collaboration with Amazon Web Services (AWS) to leverage generative AI in transforming healthcare delivery. The partnership aims to streamline processes and improve patient care through innovative technology. Additionally, the company is expanding its capabilities by acquiring a clinical artificial intelligence business from Intelligent Ultrasound, which is expected to further add to its offerings in the ultrasound sector.

Recently, GE HealthCare (NASDAQ:GEHC) announced FDA’s approval of its Flyrcado (flurpiridaz F 18), a new diagnostic agent for heart health. The product is designed for the detection of coronary artery disease (CAD), a leading cause of mortality. Flyrcado is notable for its ability to provide higher diagnostic accuracy than traditional single-photon emission computed tomography (SPECT), offering a more reliable means of assessing blood flow in the heart.